Seven Fleet Capital Management »

Neurogene shares owned by Seven Fleet Capital Management

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Seven Fleet Capital Management from 13F filings

Historical chart of Seven Fleet Capital Management investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Seven Fleet Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Seven Fleet Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $694k 22k 31.45

More positions owned by Seven Fleet Capital Management

Cg Oncology (CGON)
Tango Therapeutics (TNGX)
Revolution Medicines (RVMD)
Pharvaris N V (PHVS)
Liquidia Corporation Com New (LQDA)
Enliven Therapeutics (ELVN)
Abivax Sa Sponsored Ads (ABVX)
Avalo Therapeutics Com New (AVTX)
Mirum Pharmaceuticals (MIRM)
Assembly Biosciences Com New (ASMB)
Century Therapeutics (IPSC)
Cytokinetics Com New (CYTK)
Taysha Gene Therapies Com Shs (TSHA)
Veradermics Common Stock (MANE)
Arrivent Biopharma (AVBP)

View all positions for Seven Fleet Capital Management

Top funds holding Neurogene

Samsara BioCapital
Casdin Capital
Redmile Group
Rtw Investments
EcoR1 Capital
BlackRock
Baker Bros. Advisors
Balyasny Asset Management
Trails Edge Capital Partners
Toronto-Dominion Bank
Vanguard Capital Management
Jennison Associates
Citadel Advisors
Dr. Jeffrey R. Jay, M.D.
Arrowpoint Asset Management

View all funds holding Neurogene